Prime Capital Investment Advisors’s NeoGenomics NEO Stock Holding History

Prime Capital Investment Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,261	Closed	-$61K	–	487
2021 Q1	$61K	Sell	1,261 -117	-8%	-$6.09K	﹤0.01%	321
2020 Q4	$74K	Sell	1,378 -133	-9%	-$6.01K	0.01%	296
2020 Q3	$56K	Sell	1,511 -572	-27%	-$21.3K	﹤0.01%	304
2020 Q2	$65K	Buy	2,083 +1,083	+108%	+$30K	0.01%	301
2020 Q1	$28K	Hold	1,000	–	–	﹤0.01%	326
2019 Q4	$29K	Hold	1,000	–	–	﹤0.01%	365
2019 Q3	$19K	Buy	+1,000	New	+$23.5K	﹤0.01%	428

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Prime Capital Investment Advisors's NEO Position: Q2 2021 in Review

Prime Capital Investment Advisors sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 1,261 shares — an estimated $61K sold.

Prime Capital Investment Advisors first reported a position in NEO in Q3 2019 and held it in 7 quarters. The position peaked at $74K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

Prime Capital Investment Advisors reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
Prime Capital Investment Advisors sold 1,261 NeoGenomics shares in Q2 2021, an estimated $61K.
Prime Capital Investment Advisors first reported a position in NeoGenomics in Q3 2019 and held it in 7 quarters.
Prime Capital Investment Advisors's NeoGenomics position peaked at $74K in Q4 2020.
311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.